COVID-19: Which Drug, When, and Why?

Expert faculty present concise Medical Minute presentations and podcasts and author ClinicalThought commentaries and a downloadable slideset on the optimal use of treatments for COVID-19. Specific topics include antiviral agents monoclonal antibodies and anti-inflammatories/immunomodulators.

Share

Program Content

Activities

Slideset: Anti-inflammatories and Immunomodulators
COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 07, 2022

Expires: April 06, 2023

Slideset: Antiviral Agents
COVID-19: Which Drug, When, and Why? Antiviral Agents
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2022

Expires: April 24, 2023

Slideset: Monoclonal Antibody Treatments
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2022

Expires: April 14, 2023

Activities

COVID-19 Treatments
COVID-19: The Importance of Early Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2022

Expires: May 02, 2023

Activities

COVID-19 Anti-inflammatory Agents and Immunomodulators
COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 07, 2022

Expires: April 06, 2023

COVID-19 Antiviral Agents
COVID-19: Which Drug, When, and Why? Antiviral Agents
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2022

Expires: April 24, 2023

COVID-19 Monoclonal Antibodies
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2022

Expires: April 20, 2023

Provided by

ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.